Astria Therapeutics, Inc.

Pharmaceutical Preparations·BOSTON, MA

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/12/25	→
10-Q	Q2 2025	6/30/25	8/12/25	→
10-Q	Q1 2025	3/31/25	5/13/25	→
10-K	FY 2024	12/31/24	3/11/25	→
10-Q	Q3 2024	9/30/24	11/13/24	→
10-Q	Q2 2024	6/30/24	8/12/24	→
↓

Earnings Releases (8-K)

8 shown

Filed	Period
11/12/25	Q4 FY2025	→
10/14/25	Q3 FY2025	→
3/11/25	Q1 FY2025	→
11/13/23	Q4 FY2023FROM 8-K	→
3/22/23	Q1 FY2023	→
1/5/23	Q4 FY2023	→
↓

News (8-K)

72 shown

Filed	Type	Description
1/23/26	Delisting	Entry into a Material Definitive Agreement	→
1/21/26	Vote	Submission of Matters to a Vote of Security Holders	→
12/23/25	Other	Other Events	→
8/6/25	Agreement	Entry into a Material Definitive Agreement	→
6/12/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
1/13/25	Reg FD	Regulation FD Disclosure	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
1/23/26	S-8 POS	S-8 POS	→
1/23/26	S-8 POS	S-8 POS	→
1/23/26	S-8 POS	S-8 POS	→
1/23/26	S-8 POS	S-8 POS	→
1/23/26	S-8 POS	S-8 POS	→
1/23/26	S-8 POS	S-8 POS	→
↓

Filing History(628 filings)

TypeDateAccessionPeriodSize

SCHEDULE 13G/A

Feb 17, 2026

0000902664-26-001087

—

10.0 KB

SCHEDULE 13G/A

Feb 12, 2026

0001076809-26-000024

—

9.1 KB

SCHEDULE 13D/A

Feb 9, 2026

0001193125-26-042995

—

10.2 KB

15-12G

Feb 2, 2026

0001140361-26-00321915-12G

—

12.1 KB

SCHEDULE 13D/A

Jan 28, 2026

0001104659-26-007234

—

31.0 KB

EFFECT

Jan 27, 2026

9999999995-26-000311

—

1.8 KB

EFFECT

Jan 27, 2026

9999999995-26-000310

—

1.8 KB

EFFECT

Jan 27, 2026

9999999995-26-000308

—

1.8 KB

EFFECT

Jan 27, 2026

9999999995-26-000307

—

1.8 KB

EFFECT

Jan 27, 2026

9999999995-26-000306

—

1.8 KB

EFFECT

Jan 27, 2026

9999999995-26-000305

—

1.8 KB

25-NSE/A

Jan 26, 2026

0001354457-26-000086

—

3.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002233S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002232S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002231S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002230S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002229S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002228S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002227S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002226S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002225S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002224S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002223S-8 POS

—

27.0 KB

S-8 POS

Jan 23, 2026

0001140361-26-002222S-8 POS

—

27.0 KB

Jan 23, 2026

0000905148-26-000324

Jan 23, 2026

16.5 KB

25 filings shown

Filed	Form	Description
12/18/25	DEFM14A	DEFM14A	→
4/28/25	DEFA14A	DEFA14A	→
4/28/25	DEF 14A	FORM-DEF 14A	→
4/22/24	DEFA14A	DEFA14A	→
4/22/24	DEF 14A	DEF 14A	→
4/20/23	DEFA14A	DEFA14A	→
↓

Astria Therapeutics, Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(628 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/17/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/12/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
2/9/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
2/2/26	15-12G	15-12G	→
1/28/26	SCHEDULE 13D/A	SCHEDULE 13D/A	→
1/27/26	EFFECT	EFFECT	→
↓